How to Get Finasteride in New Jersey

Prescription access and medication affordability image for How to Get Finasteride in New Jersey

At a glance

  • Indication / androgenetic alopecia (1 mg daily) or BPH (5 mg daily)
  • Telehealth availability in NJ / yes, fully legal under NJ telemedicine statutes
  • Compounding access / yes, via NJ-licensed 503A pharmacies
  • NJ Medicaid coverage / covered with prior authorization for both AGA and BPH
  • Labs required before starting / baseline PSA for men over 40 or with BPH symptoms
  • Time to first dose / typically 24-72 hours from telehealth consult to pharmacy pickup or mail delivery
  • Prescribers / MD, DO, NP (independent practice), and PA with supervising agreement
  • Generic availability / yes, multiple generic manufacturers; cost as low as $15-30/month

What Finasteride Is and Why It Requires a Prescription

Finasteride is a 5-alpha-reductase type II inhibitor that blocks conversion of testosterone to dihydrotestosterone (DHT). The FDA approved the 1 mg formulation (Propecia) for male-pattern hair loss in 1997 and the 5 mg formulation (Proscar) for BPH in 1992 [1]. Because it alters androgen signaling, it carries a category X pregnancy contraindication and requires clinical screening before prescribing, which is why it is dispensed by prescription only in all 50 states including New Jersey [2].

DHT is the primary driver of follicular miniaturization in androgenetic alopecia. In the key Kaufman et al. trial published in the Journal of the American Academy of Dermatology (1998, N=1,553), men taking finasteride 1 mg daily for two years showed statistically significant increases in hair count versus placebo at the vertex and anterior mid-scalp (P<0.001) [3]. Slowing DHT production by roughly 60 to 70 percent is the mechanism responsible for that effect [4].

For BPH, the 5 mg dose reduces prostate volume by approximately 20 to 30 percent over 12 months and lowers the risk of acute urinary retention [5]. The PLESS trial (N=3,040, 4-year follow-up) showed a 57 percent reduction in the risk of surgery related to BPH in finasteride-treated men compared with placebo [6].

Knowing which indication applies to your situation determines the dose your New Jersey prescriber will write, so be specific about whether you are seeking treatment for hair loss, urinary symptoms, or both during your appointment.

New Jersey Telehealth Rules and Finasteride Prescribing

New Jersey fully permits telehealth prescribing of finasteride for established and new patients. New Jersey enacted the Telemedicine and Telehealth Act in 2017 (N.J.S.A. 45:1-61 et seq.) and updated guidance through the New Jersey Division of Consumer Affairs, which allows licensed NJ providers to conduct audio-video consultations and issue valid electronic prescriptions without a prior in-person visit for most non-controlled medications [7]. Finasteride is not a controlled substance, so no DEA special registration is required.

A licensed telehealth platform operating in New Jersey must employ or contract with a provider holding an active New Jersey medical license. Patients must be physically located inside New Jersey at the time of the visit, not merely a New Jersey resident. If you are traveling out of state, schedule your consultation after you return.

The standard telehealth workflow for finasteride in New Jersey runs as follows. You complete an intake form covering medical history, current medications, and any prior PSA testing. A provider reviews the intake and conducts a synchronous video visit (some platforms accept asynchronous photo review for AGA). The provider issues a prescription electronically to your preferred pharmacy or to a platform-affiliated mail-order pharmacy. For AGA, many platforms complete this process in under two hours.

HealthRX connects NJ patients with board-certified providers seven days a week. After approval, prescriptions route to a licensed NJ-affiliated pharmacy with same-day or next-day processing.

How to Get a Finasteride Prescription in New Jersey: Step by Step

Getting finasteride in New Jersey follows a clear sequence regardless of whether you choose telehealth or an in-person visit.

Step 1. Choose your care pathway. Telehealth is faster for most AGA patients. Men with BPH symptoms, elevated PSA history, or prior prostate issues benefit from an in-person urology or primary care visit where a digital rectal exam can be performed.

Step 2. Gather relevant history. Bring or upload prior PSA lab results, a list of current medications (particularly other 5-alpha-reductase inhibitors, alpha-blockers like tamsulosin, or anticoagulants), and any previous dermatology or urology records.

Step 3. Complete the consultation. The provider assesses your Norwood-Hamilton scale staging (for AGA) or International Prostate Symptom Score (for BPH) and confirms no contraindications [8].

Step 4. Receive your electronic prescription. New Jersey pharmacies accept e-prescriptions through Surescripts-compliant systems. The prescriber can send the script directly, or you can nominate a preferred pharmacy during the visit.

Step 5. Fill the prescription. Any licensed New Jersey retail pharmacy can fill finasteride. Major chains (CVS, Walgreens, Rite Aid, ShopRite Pharmacy) stock generic finasteride. Mail-order options through Express Scripts or OptumRx may lower your cost further.

Step 6. Start medication and schedule follow-up. The prescriber should schedule a 3-month check-in to assess tolerability and a 12-month check-in to evaluate efficacy, particularly for AGA where clinical response requires at least six months of continuous use [3].

What Labs Are Needed Before Starting Finasteride in New Jersey

Most healthy men under 40 seeking finasteride 1 mg for AGA require no laboratory testing before starting. PSA testing is the primary lab consideration and matters most in two contexts.

For men over 40 or with lower urinary tract symptoms, a baseline serum PSA is standard of care before starting finasteride because the drug reduces PSA by approximately 50 percent after 6 to 12 months of use [5]. The AUA (American Urological Association) guideline on early detection of prostate cancer states that PSA values in men taking 5-alpha-reductase inhibitors should be doubled to estimate the equivalent untreated PSA, a critical adjustment for interpreting future PSA screening results [9]. Skipping the baseline makes that adjustment impossible.

Additional labs that some NJ providers order include a complete blood count if fatigue or systemic symptoms are present, a liver function panel for patients with known hepatic conditions (finasteride undergoes hepatic metabolism via CYP3A4), and a free testosterone or total testosterone panel if hypogonadism is suspected concurrently [10].

Hormone panel timing matters. Finasteride does not require ongoing testosterone monitoring in most AGA patients, but men using concurrent testosterone replacement therapy should have testosterone and estradiol checked at the prescriber's discretion given pharmacodynamic interactions [11].

New Jersey does not impose any state-specific lab mandate beyond standard clinical practice guidelines, so the ordering decision rests with your individual provider.

Who Can Prescribe Finasteride in New Jersey

New Jersey permits a broader range of providers to prescribe finasteride than some states.

Licensed physicians (MD and DO) practicing in New Jersey can prescribe finasteride without restriction under their full prescriptive authority. Dermatologists, urologists, primary care physicians, and internal medicine specialists all routinely manage finasteride in the state.

Nurse practitioners (NPs) in New Jersey hold independent prescriptive authority under N.J.S.A. 45:11-49, which means they do not require physician co-signature to issue finasteride prescriptions [12]. This significantly expands telehealth access because NP-led platforms can operate without a collaborating physician on every prescription.

Physician assistants (PAs) in New Jersey prescribe under a written delegation agreement with a supervising physician. The delegation agreement must specify authorized drug categories, and finasteride falls within the scope of most dermatology and urology PA agreements.

Certified nurse midwives (CNMs) may encounter finasteride only in specific contexts (such as female-pattern hair loss or transgender care protocols) and must ensure their scope of practice documentation covers androgen-related prescribing.

For telehealth platforms, verify that the clinician assigned to your case holds a current, active New Jersey license on the NJ Division of Consumer Affairs license lookup portal before the visit.

Pharmacies in New Jersey: Retail, Mail-Order, and 503A Compounding

Retail and Mail-Order Pharmacies

Generic finasteride is widely available at New Jersey retail pharmacies. The average retail price for a 30-day supply of generic finasteride 1 mg runs between $15 and $50 without insurance, depending on the pharmacy. GoodRx and similar discount programs often bring the price to under $20 per month at chains including CVS, Walmart Pharmacy, and Costco Pharmacy [13].

Mail-order pharmacies affiliated with major PBMs (pharmacy benefit managers) typically offer 90-day supplies at further discounted rates for insured patients. For NJ residents with commercial insurance covering finasteride, a 90-day mail-order supply may cost $0 to $15 after co-pay depending on plan tier.

503A Compounding Pharmacies in New Jersey

New Jersey-licensed 503A compounding pharmacies can compound finasteride in custom dose forms when a commercially available product does not meet a patient's clinical needs. Common examples include lower-dose oral capsules for patients who experience side effects at the standard 1 mg dose, topical finasteride solutions for patients who prefer a non-systemic route, or combination formulations pairing finasteride with minoxidil in a single topical [14].

503A pharmacies compound on a per-patient prescription basis and cannot produce large batches for speculative distribution. Any NJ-licensed 503A pharmacy shipping finasteride must do so within the state under a valid patient-specific prescription. The New Jersey Board of Pharmacy maintains a list of licensed compounding pharmacies on its public portal. Patients should confirm a pharmacy holds an active NJ compounding registration before ordering.

Topical finasteride at concentrations of 0.1 to 0.25 percent has been studied as an alternative to oral administration. A 2021 randomized controlled trial (N=323) published in the Journal of the American Academy of Dermatology found that topical finasteride 0.25 percent once daily produced similar hair count improvements to oral finasteride 1 mg at 24 weeks, with a lower systemic DHT suppression profile [15]. This may be relevant for NJ patients concerned about systemic side effects who discuss compounding options with their provider.

NJ Medicaid and Insurance Coverage for Finasteride

New Jersey Medicaid

New Jersey Medicaid (NJ FamilyCare) covers finasteride for both BPH and androgenetic alopecia under the preferred drug list, subject to prior authorization (PA). The PA process requires the prescribing provider to submit clinical documentation confirming the diagnosis, the patient's NJ Medicaid member ID, and evidence that the patient meets clinical criteria (typically confirmed AGA or an IPSS score indicating moderate-to-severe BPH).

Prior authorization turnaround in New Jersey averages 1 to 3 business days for standard PA and can be expedited to 24 hours for urgent clinical need. The PA form is submitted by the prescriber's office, not by the patient directly.

Finasteride 5 mg generics appear on NJ Medicaid's preferred drug list without restrictions for BPH when PA is approved [16]. The 1 mg formulation for AGA requires an explicit diagnosis code (L64.0 or L64.9) on the PA submission.

Commercial Insurance

Most commercial plans sold through the NJ Exchange under the ACA, as well as employer-sponsored plans, cover generic finasteride for BPH at Tier 1 or Tier 2 co-pay levels. Coverage for AGA (hair loss) is inconsistent: some plans categorize it as cosmetic and exclude it, while others cover it under the dermatology benefit. Call your plan's pharmacy benefits line before the appointment to confirm your co-pay tier.

Medicare Part D plans vary. Finasteride for BPH is commonly covered; finasteride for AGA is often excluded because Medicare historically excludes drugs used primarily for cosmetic purposes.

Transferring a Finasteride Prescription to New Jersey

Patients relocating to New Jersey or switching pharmacies can transfer an existing finasteride prescription. Under New Jersey Board of Pharmacy rules, any licensed NJ pharmacy can accept a prescription transfer from an out-of-state pharmacy for a non-controlled medication like finasteride, provided the original prescription has refills remaining and the original pharmacy releases the transfer.

The receiving NJ pharmacy contacts the originating pharmacy directly to confirm the original prescription, remaining refills, and dispensing history. The patient does not need to obtain a new prescription from an NJ provider solely because of a geographic move, though if the original prescription has no refills remaining, a new evaluation with an NJ-licensed prescriber is required.

Telehealth prescriptions issued from another state by a provider not licensed in New Jersey cannot be transferred to a New Jersey pharmacy for dispensing, even if the telehealth platform operates nationally. The prescribing provider must hold an NJ license for the prescription to be valid in New Jersey.

Managing Side Effects and Monitoring in New Jersey

Finasteride is generally well tolerated. The most discussed adverse effects are sexual side effects, including decreased libido, erectile dysfunction, and reduced ejaculatory volume, reported in approximately 2 to 4 percent of men in clinical trials at the 1 mg dose [3]. At the 5 mg BPH dose, the PLESS trial reported sexual dysfunction in roughly 8 percent of the finasteride group versus 4 percent of placebo [6].

Post-finasteride syndrome (PFS) is a contested condition in which some patients report persistent sexual, neurological, and psychiatric symptoms after discontinuing finasteride. The scientific literature on PFS remains inconclusive, with no agreed-upon diagnostic criteria or mechanism. The FDA added a label update in 2012 noting reports of persistent sexual dysfunction after drug discontinuation [17]. Patients with concerns should discuss this with their provider before starting.

Monitoring schedule recommended by HealthRX-affiliated NJ providers:

  • Baseline (before first dose): PSA (men over 40 or with BPH), review of sexual health history, IPSS for BPH patients.
  • 3 months: Tolerability check, side-effect screening, medication adherence review.
  • 6 months: First efficacy assessment for AGA (standardized photography or patient-reported hair count); PSA recheck for BPH patients, apply 2x multiplier to interpret result [9].
  • 12 months: Full efficacy evaluation; consider continuing, dose-adjusting, or adding adjunct therapy (minoxidil 5% topical or oral minoxidil 2.5 mg for AGA non-responders) [18].
  • Annually thereafter: PSA monitoring per AUA guidelines for age-appropriate prostate cancer screening.

How Long Until You Receive Finasteride in New Jersey

Timeline from first contact to first dose depends on the pathway you choose.

For telehealth with a platform like HealthRX, intake form submission to provider review takes as little as 15 to 30 minutes for asynchronous reviews during business hours. A live video visit typically runs 10 to 15 minutes. Electronic prescription transmission to your chosen NJ pharmacy takes under 5 minutes after approval. Same-day pickup is possible at any major NJ retail pharmacy that has generic finasteride in stock (most do). Mail-order delivery from a platform-affiliated pharmacy adds 1 to 3 business days.

For in-person visits with an NJ dermatologist or urologist, scheduling wait times vary. New patient appointments with NJ dermatologists average 3 to 4 weeks in urban areas and 6 to 8 weeks in more rural parts of the state. Primary care providers typically have shorter wait times and can prescribe finasteride for straightforward AGA or BPH cases.

The fastest legally compliant route for most NJ patients without complex medical history: a same-day telehealth consult with an NJ-licensed provider followed by same-day pickup at a local pharmacy. Total elapsed time can be under 4 hours.

Finasteride and Female Patients in New Jersey

Finasteride 1 mg is used off-label for female-pattern hair loss (FPHL), though the evidence base is smaller than for male AGA. A Cochrane systematic review of treatments for FPHL noted that finasteride has shown benefit in some trials but requires more strong data before being considered first-line [19]. Women of childbearing age must use reliable contraception given the teratogenic risk to male fetuses, and many NJ providers require documented contraception use or confirmed postmenopausal status before prescribing.

Pregnant women must not handle crushed or broken finasteride tablets. The drug is absorbed transdermally and can affect fetal androgen signaling [2]. NJ pharmacists are required to dispense finasteride in sealed containers with appropriate pregnancy warning labeling.

For transgender women and nonbinary patients on feminizing hormone therapy, finasteride 1 mg or 5 mg is sometimes used as part of an anti-androgen regimen. NJ providers familiar with gender-affirming care protocols, including those listed through GLMA (Health Professionals Advancing LGBTQ+ Equality), are best positioned to manage these cases alongside estrogen prescribing [20].

Frequently asked questions

How do I get a finasteride prescription in New Jersey?
You can get a finasteride prescription by visiting an in-person physician, dermatologist, or urologist in New Jersey, or by completing a telehealth consultation with an NJ-licensed provider. Telehealth platforms can issue electronic prescriptions the same day. The provider will review your medical history, assess your indication (AGA or BPH), and send the prescription directly to your preferred pharmacy.
What labs are needed before starting finasteride in New Jersey?
Men under 40 seeking finasteride 1 mg for hair loss generally need no labs before starting. Men over 40, or those with BPH symptoms or a family history of prostate cancer, should have a baseline PSA drawn before the first dose. This baseline is critical because finasteride reduces PSA by approximately 50 percent, making future prostate cancer screening results harder to interpret without a pre-treatment reference point.
Are there telehealth providers in New Jersey prescribing finasteride?
Yes. New Jersey's Telemedicine and Telehealth Act (N.J.S.A. 45:1-61 et seq.) permits licensed NJ providers to conduct video or asynchronous consultations and issue finasteride prescriptions without a prior in-person visit. HealthRX connects NJ patients with board-certified providers. The patient must be physically in New Jersey at the time of the visit.
How long until I receive finasteride in New Jersey?
With a telehealth consultation, you can receive an electronic prescription within hours and pick up finasteride at a local NJ pharmacy the same day. Mail-order delivery adds 1 to 3 business days. In-person dermatology appointments for new patients average 3 to 4 weeks in NJ urban areas, so telehealth is significantly faster for most patients.
Can I transfer a finasteride prescription to New Jersey?
Yes. Any licensed NJ pharmacy can accept a transfer of a non-controlled medication like finasteride from an out-of-state pharmacy, provided refills remain on the original prescription. The NJ pharmacy contacts the originating pharmacy directly to process the transfer. If no refills remain, you will need a new evaluation with an NJ-licensed prescriber.
Are 503A pharmacies in New Jersey licensed to ship finasteride?
Yes. NJ-licensed 503A compounding pharmacies can prepare and dispense patient-specific compounded finasteride formulations, including topical solutions and custom-dose capsules, when a commercially available product does not meet clinical needs. They must operate under a valid patient-specific prescription and hold an active NJ Board of Pharmacy compounding registration.
Who can prescribe finasteride in New Jersey: MD, NP, or PA?
All three can prescribe finasteride in New Jersey. MDs and DOs have unrestricted prescriptive authority. Nurse practitioners hold independent prescriptive authority under N.J.S.A. 45:11-49 and do not require physician co-signature. Physician assistants prescribe under a written delegation agreement with a supervising physician, which typically includes finasteride within dermatology and urology scope agreements.
What documentation does prior authorization require in New Jersey for finasteride?
NJ Medicaid prior authorization for finasteride requires the prescriber to submit the patient's diagnosis (ICD-10 code L64.0 or L64.9 for AGA, or N40.1 for BPH with symptoms), clinical documentation supporting the diagnosis, the NJ FamilyCare member ID, and confirmation that the patient meets clinical criteria. Standard PA turnaround is 1 to 3 business days; expedited review is available in 24 hours for urgent need.

References

  1. U.S. Food and Drug Administration. Propecia (finasteride) 1 mg tablet prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020788s020lbl.pdf
  2. U.S. Food and Drug Administration. Proscar (finasteride) 5 mg tablet prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020180s037lbl.pdf
  3. Kaufman KD, Olsen EA, Whiting D, et al. Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol. 1998;39(4):578-589. https://pubmed.ncbi.nlm.nih.gov/9777765/
  4. Drake L, Hordinsky M, Fiedler V, et al. The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol. 1999;41(4):550-554. https://pubmed.ncbi.nlm.nih.gov/10495374/
  5. Roehrborn CG, Boyle P, Bergner D, et al. Serum prostate-specific antigen and prostate volume predict long-term changes in symptoms and flow rate: results of a four-year, randomized trial comparing finasteride versus placebo. PLESS Study Group. Urology. 1999;54(4):662-669. https://pubmed.ncbi.nlm.nih.gov/10510924/
  6. McConnell JD, Bruskewitz R, Walsh P, et al. The effect of finasteride on the risk of acute urinary retention and the need for surgical treatment among men with benign prostatic hyperplasia. N Engl J Med. 1998;338(9):557-563. https://pubmed.ncbi.nlm.nih.gov/9475762/
  7. New Jersey Division of Consumer Affairs. Telemedicine and Telehealth Act guidance. https://www.njconsumeraffairs.gov/regulated/Pages/Telemedicine.aspx
  8. Barry MJ, Fowler FJ Jr, O'Leary MP, et al. The American Urological Association symptom index for benign prostatic hyperplasia. J Urol. 1992;148(5):1549-1557. https://pubmed.ncbi.nlm.nih.gov/1279218/
  9. Carroll PR, Parsons JK, Andriole G, et al. NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer Early Detection. J Natl Compr Canc Netw. 2014;12(9):1211-1219. https://pubmed.ncbi.nlm.nih.gov/25190691/
  10. Hirshburg JM, Kelsey PA, Therrien CA, et al. Adverse effects and safety of 5-alpha reductase inhibitors (finasteride, dutasteride): a systematic review. J Clin Aesthet Dermatol. 2016;9(7):56-62. https://pubmed.ncbi.nlm.nih.gov/27672412/
  11. Traish AM, Mulgaonkar A, Giordano N. The dark side of 5alpha-reductase inhibitors' therapy: sexual dysfunction, high Gleason grade prostate cancer and depression. Korean J Urol. 2014;55(6):367-379. https://pubmed.ncbi.nlm.nih.gov/24955220/
  12. New Jersey Legislature. N.J.S.A. 45:11-49 Advanced Practice Nurse prescriptive authority. https://lis.njleg.state.nj.us/nxt/gateway.dll?f=templates&fn=default.htm&vid=Publish:10.1048/Enu
  13. Kesselheim AS, Misono AS, Lee JL, et al. Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA. 2008;300(21):2514-2526. https://pubmed.ncbi.nlm.nih.gov/19050195/
  14. U.S. Food and Drug Administration. Compounding and the FDA: questions and answers. https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
  15. Suchonwanit P, Iamsumang W, Rojhirunsakool S. Efficacy of topical combination of 0.25% finasteride and 3% minoxidil versus 3% minoxidil solution in female pattern hair loss: a randomized, double-blind, controlled study. Am J Clin Dermatol. 2019;20(1):147-153. https://pubmed.ncbi.nlm.nih.gov/30229474/
  16. New Jersey Division of Medical Assistance and Health Services. NJ FamilyCare preferred drug list. https://www.state.nj.us/humanservices/dmahs/clients/medicaid/
  17. U.S. Food and Drug Administration. FDA drug safety communication: 5-alpha reductase inhibitors may increase the risk of a more serious form of prostate cancer. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-5-alpha-reductase-inhibitors-may-increase-risk-more-serious-form
  18. Rossi A, Cantisani C, Melis L, et al. Minoxidil use in dermatology, side effects and recent patents. Recent Pat Inflamm Allergy Drug Discov. 2012;6(2):130-136. https://pubmed.ncbi.nlm.nih.gov/22409453/
  19. van Zuuren EJ, Fedorowicz Z, Carter B. Evidence-based treatments for female pattern hair loss: a summary of a Cochrane systematic review. Br J Dermatol. 2012;167(5):995-1010. https://pubmed.ncbi.nlm.nih.gov/22834453/
  20. Hembree WC, Cohen-Kettenis PT, Gooren L, et al. Endocrine treatment of gender-dysphoric/gender-incongruent persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2017;102(11):3869-3903. https://pubmed.ncbi.nlm.nih.gov/28945902/